Drug: esomeprazole Quarter: 2016Q3
Total Records: 283 Number of Pages: 15
| DRUGNAME | PT | EventCount |
|---|---|---|
| ESOMEPRAZOLE MYLAN//ESOMEPRAZOLE | Acute kidney injury | 1 |
| ESOMEPRAZOLE NAGNESIUM DELAYED-RELEASE CAPSULES, USP 40MG MYLAN | Dyspepsia | 1 |
| ESOMEPRAZOLE NAGNESIUM DELAYED-RELEASE CAPSULES, USP 40MG MYLAN | Nausea | 1 |
| ESOMEPRAZOLE NAGNESIUM DELAYED-RELEASE CAPSULES, USP 40MG MYLAN | Product substitution issue | 1 |
| ESOMEPRAZOLE PRESCRIPTION | Cardiac murmur | 1 |
| ESOMEPRAZOLE PRESCRIPTION | Injection site extravasation | 1 |
| ESOMEPRAZOLE PRESCRIPTION | Injection site haemorrhage | 1 |
| ESOMEPRAZOLE PRESCRIPTION | Off label use | 1 |
| ESOMEPRAZOLE SODIUM. | Condition aggravated | 1 |
| ESOMEPRAZOLE SODIUM. | Dermatitis | 1 |
| ESOMEPRAZOLE SODIUM. | Intentional product use issue | 1 |
| ESOMEPRAZOLE SODIUM. | Product use issue | 1 |
| ESOMEPRAZOLE SODIUM. | Pruritus | 1 |
| ESOMEPRAZOLE SODIUM. | Rash erythematous | 1 |
| ESOMEPRAZOLE SODIUM. | Rash morbilliform | 1 |
| ESOMEPRAZOLE W/NAPROXEN | IgA nephropathy | 1 |
| ESOMEPRAZOLE W/NAPROXEN | Inflammation | 1 |
| ESOMEPRAZOLE W/NAPROXEN | Liver disorder | 1 |
| ESOMEPRAZOLE W/NAPROXEN | Oedema | 1 |
| ESOMEPRAZOLE W/NAPROXEN | Vasculitic rash | 1 |
Total Records: 283 Number of Pages: 15